About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
2021 Virtual KU Hematology and Medical Oncology Review
https://www.kucancercenter.org/
Videos
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Early Stage Patients, Platinum-Based Chemo vs. Capecitabine in Residual Disease
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Qamar Khan
By
2021 Virtual KU Hematology and Medical Oncology Review
FEATURING
Qamar Khan
201 views
July 22, 2021
0 Comments
Login to view comments.
Click here to Login
Videos
43:11
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial…
Feat.
B. Van Tine
25:06
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…
Feat.
E. Wulff-Burchfield
30:04
2021 Virtual KU Hematology and Medical Oncology Review
2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials
Feat.
B. Burtness
09:13
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…
Feat.
B. Burtness
18:15
2021 Virtual KU Hematology and Medical Oncology Review
KUMC Highlights on mCRC: Recent Data on Changes in the SoC
Feat.
W. Sun
06:25
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…
Feat.
S. Abbasi
08:08
2021 Virtual KU Hematology and Medical Oncology Review
2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Gov…
Feat.
S. Abbasi
15:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & B…
Feat.
A. Yacoub
05:01
2021 Virtual KU Hematology and Medical Oncology Review
2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…
Feat.
A. Yacoub
10:52
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…
Feat.
A. Abdallah
07:17
2021 Virtual KU Hematology and Medical Oncology Review
2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…
Feat.
A. Abdallah
27:42
2021 Virtual KU Hematology and Medical Oncology Review
CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…
Feat.
J. McGuirk
10:44
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…
Feat.
Q. Khan
08:59
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…
Feat.
Q. Khan
10:17
2021 Virtual KU Hematology and Medical Oncology Review
ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…
Feat.
Q. Khan
